文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > A Novel Link Between SUMO Modification and Cancer Metastasis
侵权投诉

A Novel Link Between SUMO Modification and Cancer Metastasis

A Novel Link Between SUMO Modification and Cancer Metastasis

such as LNCaP cells. This was in contrastto the expression levels detected in RWPE1normal prostate epithelial cells. Matrigelinvasion assay confirmed that Ubc9 andSENP1 could modulate the invasive activityof LNCaP and RWPE1 cells. Figure 1summarizes our finding regarding the rolesof SUMOylation of reptin chromatinremodeling complexes in the regulation ofKAI1metastasis suppressor gene.

It would be interesting to employmicroarray approaches and proteomicapproaches to find differentially expressedSUMO modified proteins between normaland metastatic cancer cells. Since theexpression levels of SUMO conjugatingenzymes are dramatically increased inmetastatic cancer cells,9we speculated thatcertain proteins related to progression ofcancer and/or cancer metastasis areSUMOylated by Ubc9 SUMO conjugatingenzymes for carrying out an importantfunction in the biological process. It wouldalso be interesting to examine other tissuesto determine whether a correlation betweenSUMO modification and cancer metastasis

exist, as well as whether upstream signals,which affect the SUMOylation levels inthe cellular context.

In conclusion, our recent results shednew light on the relationship betweenSUMOylation and cancer metastasis byrevealing new factors that control metastasis,which could be potential targets for thera-peutic intervention. Since a number ofoncogenes and tumor suppressor genes are

changes brought about by SUMOylation and the relatively lowemerging as targets for SUMOylation, we can speculate that thepercentage of SUMOylation of most substrates, exciting questionsSUMOylation status of proteins involved in tumorigenesis andregarding the functional significance of this modification remaincancer metastasis might be altered in cancer and might provide aunanswered. Furthermore, the upstream signals of SUMOylationgood indication for diagnosis. Using genomic and proteomicand the following regulation of substrate SUMOylation are yet to beapproaches, it is necessary to determine the target genes that areclarified, particularly with regard to physiological and pathologicaldifferentially regulated by SUMO modification in normal andconditions including cancer metastasis.cancer cells. In addition, the elucidation of the upstream signal forMore insight into the functional implications of SUMOylationSUMO modification of these proteins may shed light on thein cancer metastasis was derived from an interesting correlationfunctional significance of SUMOylation in the context of humanbetween the SUMOylation status of reptin and the expression levelscancer. Since SUMOylation and deSUMOylation are dynamicof SUMO conjugating/deconjugating enzymes in normal andprocesses, it is necessary to pay attention to both of these processes.metastatic cancer cells.9The levels of endogenously SUMOylatedFurther studies are required to elucidate the biological importance ofreptin protein were compared using immunoblot analysis in RWPE1protein SUMOylation and its role and relationship with variousnormal prostate epithelial cells and LNCaP metastatic prostatedisease states.cancer cells. This analysis revealed a higher level of reptinReferencesSUMOylation in LNCaP cells compared with that in RWPE1 cells.1.Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in

metastatic sites. Nature Rev Cancer 2002; 2:563-72.We tried to determine whether changes in the expression and/or

2.Condeelis J, Pollalrd JW. Macrophages: Obligate partners for tumor cell migration, inva-activities of SUMO conjugating and deconjugating enzymes would

sion, and metastasis. Cell 2006; 124:263-6.

have a significant impact on the SUMOylation status of reptin as3.Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC.well as the functional regulation of KAI1 mediated by reptin.KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2.

Science 1995; 268:884-6.Immunoblot analysis revealed that the expression of SENP1

4.Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT.deSUMOylating enzyme, which is responsible for deSUMOylation

Downregulation of the KAI1metastasis suppressor gene during the progression of human

of reptin, was decreased, whereas the expression levels of Ubc9prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res 1996;SUMO conjugating enzyme were increased in metastatic cancer cells56:4387-90.

A Novel Link Between SUMO Modification and Cancer Metastasis

1494

Cell Cycle

2006; Vol. 5 Issue 14

上一页第3页

你可能喜欢

热门文档

相关文档

  • Breast cancer adaptive resistance

    our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...

  • Breast cancer adaptive resistance

    our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email